What we do
Our approach
We deliver exceptional results: excellence is our standard
Every project benefits from our scientific prowess, strategic understanding, vast sector experience, industry best-practice know-how, and flawless project management.
We build strong partnerships with our clients and become an extension of their team.
We are committed to bringing science to life in innovative and impactful ways.
Excellence is our standard, but don’t just take our word for it!
Here’s what some of our clients have to say about working with us:
Our expertise
We deliver innovative and impactful omnichannel solutions, bringing expertise and passion to every project.
We are leaders in the following areas of healthcare communications.
Strategic consultancy:
we are insight led
Medical and scientific communications:
we are science led
Commercialisation solutions:
we are results driven
Evidence, value and market access:
we are market focused
We deliver high-quality, strategically-aligned, innovative programmes of work that resonate with your audience.
We adapt to changing landscapes to create current, creative and impactful outputs that meet your strategic commercialisation goals.
We utilise our insights and experience, coupled with the available evidence, to develop forward-thinking strategic goals and plans.
Communication strategy and planning >
- Communication plan development and implementation
- Competitor and disease area landscape analyses
- Cross-functional workshops
- Lexicon development
- Market insights
- Product strategy development
- Scientific platform and narrative development
- Stakeholder mapping
External expert strategy and engagement >
- Contractual coordination
- External expert engagement planning
- External expert identification and validation
- External expert interviews and insights
HEOR and market access solutions >
- Dossiers and resources
- Publications
- Workshops and meetings
Market insights and landscape analysis >
- Advisory boards
- Competitor intelligence
- External expert insights
- Market insights
- Disease area and landscape analyses
Healthcare transformation programmes >
- Affiliate engagement
- Digital and print materials
- Medical education activities
- Programme strategy
- Steering committee engagement and mobilisation
Medical education >
- Digital and print materials
- Educational content and meetings
- Exhibition booth materials
- Filming and video production
- Medical information resources (eg objection handlers)
- MSL education and materials
- Programme and strategy development
- Scientific platforms and narratives
- Slide libraries
- Websites
Meetings and events >
- Advisory boards
- Agenda and content development
- AV production
- Compliance approval and coordination
- Digital and print materials
- Dynamic and interactive delegate engagement experiences
- Expert identification, engagement and contracting
- Facilitation
- Logistical coordination
- Meeting reports and metrics
- On-site support
- Satellite symposia
- Standalone meetings
- Venue sourcing and management
- Webcasts
Patient engagement activities >
- Advocacy group landscape analysis, engagement and support
- Creative theming and campaigns
- Patient materials and lay summaries
- Photography
- Presentations
- Publications
- Workshops and advisory boards
Publications >
- Abstracts
- Digital publication extenders
- Editorials, letters and case reports
- Landscape and gap analyses
- Lay audience and plain language summaries
- Lexicon development
- Manuscripts
- Plenary presentations
- Posters
- Publication planning and management
- Publication steering committee engagement
- Primary and secondary manuscripts
- Review articles
- Steering committee activities
Training solutions >
- Curriculum development
- E-learning platforms
- Instructional design
- Interactive slide decks and manuals
- Objection handlers
- Preceptorships
- Speaker training
- Training and skills workshops
Commercial planning campaigns and supporting activities >
- Brand planning
- Congress activities
- Exhibition booth design
- External expert identification and engagement
- Meetings and events
- Promotional materials (digital and print)
- Sales force and MSL resources
- Speaker training
- Websites
Congress activities and exhibition booths >
- Congress planning
- Congress summaries/reports
- Exhibition booth design and interactive content
- Plenary presentations
- Secretariat engagement
- Satellite symposia
- Scientific posters
Creative branding, design and digital >
- Branding solutions
- Creative theming and design
- Data visualisation
- Digital solutions
- Exhibition booth design and content
- Infographics
- Motion graphics and showreels
- Presentation enhancement
Promotional meetings >
- Satellite symposia
- Standalone meetings
Market understanding >
- Burden of disease
- Competitive landscape and price benchmarking
- Epidemiology
- Market access landscape and strategy analysis
- Payer and external expert research
- Targeted literature reviews
- Treatment pathways and guideline analysis
Opportunity assessment >
- Access pathway and route to market
- Competitive landscape and pipeline analysis
- Early economic modelling
- Forecasting
- Indication prioritisation and portfolio decision-making
- Licensing and due diligence evaluations
- Price ranging
- Targeted literature reviews
Strategy development >
- Advisory boards
- Competitive tracking
- Evidence gap analysis and recommendations
- Market access and pricing strategy
- Payer and external expert research
- Real-world evidence generation
- Strategic workshops
- Target product profiles and value proposition
Access preparation >
- Advisory boards and workshops
- Economic and budget impact modelling
- Global value dossiers and objection handlers
- Patient access and managed entry schemes
- Value proposition development
- Payer and external expert research
- Policy/publication strategy and support
- Systematic literature reviews and evidence synthesis
Access negotiations >
- Advisory boards
- HTA submissions
- Patient access schemes
- Pricing and reimbursement negotiation
- Pricing applications and payer negotiations
- Stakeholder engagement
- Training and mock-negotiation workshops
Market support >
- Advocacy development
- Affiliate and best-practice workshops
- Competitive landscaping
- Dynamic marketplace strategy
- Lifecycle management and loss of exclusivity planning/mitigation
- Publications
- Real-world evidence generation
- Stakeholder engagement
Where we can help
Challenge
Our client teams are often part of a larger internal franchise spanning multiple products and therapy areas. They face the challenge of simultaneously delivering on their product-specific objectives and activities, while remaining aligned with a wider franchise or organisation strategy, but often lack the time or resources to achieve this. This can result in brand teams working in isolation and failing to deliver against wider strategic goals.
Our approach
We provide support across multiple brand and cross-functional client teams within the same franchise; providing specific and tailored services to support the individual needs of each brand, while also joining the dots across the portfolio through information and best-practice sharing between our internal account teams. By supporting holistically, we build a deep understanding of the strategic goals for each product within the portfolio, and how these fit together to form the overall franchise-level strategy. This enables us to better advise our clients to ensure both sets of imperatives are being met. We achieve this through close collaboration between our operational account teams coupled with strategic oversight and leadership.
Impact
Our joined-up approach brings with it many benefits to our clients:
- By understanding our client’s overarching strategy, we help to ensure individual projects are aligned with, and contribute towards, franchise- as well as brand-specific goals
- We share innovative ideas and best practice with our clients, based on what has worked well for other teams within the franchise
- Centralised processes and ways of working are applied across accounts, creating efficiencies through working with a single agency. Information is shared among our account teams, reducing the communication and training burden for our clients
Challenge
Throughout their lifecycle, products face their own unique set of challenges – whether launching first-in-class or in a crowded marketplace; obtaining approval in a first disease or add-on indications; facing regulatory barriers or receiving designated orphan drug status – we understand that no two scenarios are the same, and no two client’s requirements from their partner agency are the same. High-quality support from early phase development through to licensed product lifecycle management is vital for maximising brand potential.
Our approach
We build trusted and lasting partnerships with our clients to support them at every stage of the product lifecycle. With expertise in early-phase product strategy planning, to maximising the long-term potential of established products, we can quickly identify the unique challenges and opportunities for products at any phase of their lifecycle. We have extensive experience in pre-, peri- and post-launch activities for both first and subsequent indications, understanding the nuances of each scenario. We also support above-brand initiatives which lay the foundation for new treatments and help to establish existing products within the treatment paradigm.
Impact
Supporting brands throughout their lifecycle means that our clients enjoy working with a stable and consistent agency team that really understands their strategy and can apply context to the product journey. Understanding how to communicate about a product or therapy area consistently ensures that messaging is impactful and reaches the right audience at the right time; ultimately, resulting in better communications that directly benefit patients.
Challenge
We don’t just work with the giants of pharma or on blockbuster products: an increasing proportion of our work is within the emerging biotech space. Working in this space requires an agile approach compared with big pharma collaborations.
Many emerging biotechs are leaders in drug discovery and clinical development, however, they often require support navigating complex compliance, communication and commercialisation landscapes, and can lack well-defined processes and systems.
Our approach
For our teams, supporting emerging biotech is a hugely exciting and rewarding area to work in – many such companies are at the cutting edge of science and are drivers of innovation, often redefining treatment paradigms.
When we partner with our emerging biotech clients, we help shape the scientific communication platform and strategy. We are often viewed as an extension of their team, filling knowledge gaps in key areas and guiding them through the compliance landscape and commercialisation journey.
Impact
We add significant value in supporting our biotech clients and helping them navigate a multitude of challenges throughout the lifecycle. Our partnership approach aims to maximise their probability of success and ensures the needs of a multitude of stakeholders are met.
Challenge
Our client teams are often part of a larger internal franchise spanning multiple products and therapy areas. They face the challenge of simultaneously delivering on their product-specific objectives and activities, while remaining aligned with a wider franchise or organisation strategy, but often lack the time or resources to achieve this. This can result in brand teams working in isolation and failing to deliver against wider strategic goals.
Our approach
We provide support across multiple brand and cross-functional client teams within the same franchise; providing specific and tailored services to support the individual needs of each brand, while also joining the dots across the portfolio through information and best-practice sharing between our internal account teams. By supporting holistically, we build a deep understanding of the strategic goals for each product within the portfolio, and how these fit together to form the overall franchise-level strategy. This enables us to better advise our clients to ensure both sets of imperatives are being met. We achieve this through close collaboration between our operational account teams coupled with strategic oversight and leadership.
Impact
Our joined-up approach brings with it many benefits to our clients:
- By understanding our client’s overarching strategy, we help to ensure individual projects are aligned with, and contribute towards, franchise- as well as brand-specific goals
- We share innovative ideas and best practice with our clients, based on what has worked well for other teams within the franchise
- Centralised processes and ways of working are applied across accounts, creating efficiencies through working with a single agency. Information is shared among our account teams, reducing the communication and training burden for our clients
Challenge
Throughout their lifecycle, products face their own unique set of challenges – whether launching first-in-class or in a crowded marketplace; obtaining approval in a first disease or add-on indications; facing regulatory barriers or receiving designated orphan drug status – we understand that no two scenarios are the same, and no two client’s requirements from their partner agency are the same. High-quality support from early phase development through to licensed product lifecycle management is vital for maximising brand potential.
Our approach
We build trusted and lasting partnerships with our clients to support them at every stage of the product lifecycle. With expertise in early-phase product strategy planning, to maximising the long-term potential of established products, we can quickly identify the unique challenges and opportunities for products at any phase of their lifecycle. We have extensive experience in pre-, peri- and post-launch activities for both first and subsequent indications, understanding the nuances of each scenario. We also support above-brand initiatives which lay the foundation for new treatments and help to establish existing products within the treatment paradigm.
Impact
Supporting brands throughout their lifecycle means that our clients enjoy working with a stable and consistent agency team that really understands their strategy and can apply context to the product journey. Understanding how to communicate about a product or therapy area consistently ensures that messaging is impactful and reaches the right audience at the right time; ultimately, resulting in better communications that directly benefit patients.
Challenge
We don’t just work with the giants of pharma or on blockbuster products: an increasing proportion of our work is within the emerging biotech space. Working in this space requires an agile approach compared with big pharma collaborations.
Many emerging biotechs are leaders in drug discovery and clinical development, however, they often require support navigating complex compliance, communication and commercialisation landscapes, and can lack well-defined processes and systems.
Our approach
For our teams, supporting emerging biotech is a hugely exciting and rewarding area to work in – many such companies are at the cutting edge of science and are drivers of innovation, often redefining treatment paradigms.
When we partner with our emerging biotech clients, we help shape the scientific communication platform and strategy. We are often viewed as an extension of their team, filling knowledge gaps in key areas and guiding them through the compliance landscape and commercialisation journey.
Impact
We add significant value in supporting our biotech clients and helping them navigate a multitude of challenges throughout the lifecycle. Our partnership approach aims to maximise their probability of success and ensures the needs of a multitude of stakeholders are met.
